{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:56:34Z","timestamp":1771023394490,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006209","name":"Radboud University Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10875-017-0474-7","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T22:08:32Z","timestamp":1516054112000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation"],"prefix":"10.1007","volume":"38","author":[{"given":"Jeroen D.","family":"Langereis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie S","family":"Henriet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corry M.R.","family":"Weemaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"issue":"1","key":"474_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","volume":"27","author":"ME Conley","year":"2009","unstructured":"Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27(1):199\u2013227. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132649 .","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"474_CR2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"OC Bruton","year":"1952","unstructured":"Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9(6):722\u20138.","journal-title":"Pediatrics"},{"issue":"2","key":"474_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277\u201386. https:\/\/doi.org\/10.1182\/blood-2007-11-124545 .","journal-title":"Blood"},{"key":"474_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2017.07.008","volume":"183","author":"B Shillitoe","year":"2017","unstructured":"Shillitoe B, Gennery A. X-linked agammaglobulinaemia: outcomes in the modern era. Clin Immunol. 2017;183:54\u201362. https:\/\/doi.org\/10.1016\/j.clim.2017.07.008 .","journal-title":"Clin Immunol"},{"issue":"4","key":"474_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","volume":"85","author":"JA Winkelstein","year":"2006","unstructured":"Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85(4):193\u2013202. https:\/\/doi.org\/10.1097\/01.md.0000229482.27398.ad .","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"474_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10875-017-0374-x","volume":"37","author":"S Barmettler","year":"2017","unstructured":"Barmettler S, Otani IM, Minhas J, Abraham RS, Chang Y, Dorsey MJ, et al. Gastrointestinal manifestations in X-linked agammaglobulinemia. J Clin Immunol. 2017;37(3):287\u201394. https:\/\/doi.org\/10.1007\/s10875-017-0374-x .","journal-title":"J Clin Immunol"},{"issue":"6","key":"474_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10875-017-0420-8","volume":"37","author":"Z Chovancova","year":"2017","unstructured":"Chovancova Z, Kralickova P, Pejchalova A, Bloomfield M, Nechvatalova J, Vlkova M, et al. Selective IgM deficiency: clinical and laboratory features of 17 patients and a review of the literature. J Clin Immunol. 2017;37(6):559\u201374. https:\/\/doi.org\/10.1007\/s10875-017-0420-8 .","journal-title":"J Clin Immunol"},{"issue":"2","key":"474_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12016-013-8375-x","volume":"46","author":"AG Louis","year":"2014","unstructured":"Louis AG, Gupta S. Primary selective IgM deficiency: an ignored immunodeficiency. Clin Rev Allergy Immunol. 2014;46(2):104\u201311. https:\/\/doi.org\/10.1007\/s12016-013-8375-x .","journal-title":"Clin Rev Allergy Immunol"},{"key":"474_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01056","volume":"8","author":"S Gupta","year":"2017","unstructured":"Gupta S, Gupta A. Selective IgM deficiency-an underestimated primary immunodeficiency. Front Immunol. 2017;8:1056. https:\/\/doi.org\/10.3389\/fimmu.2017.01056 .","journal-title":"Front Immunol"},{"issue":"3","key":"474_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jaci.2011.09.047","volume":"129","author":"R Micol","year":"2012","unstructured":"Micol R, Kayal S, Mahlaoui N, Beaute J, Brosselin P, Dudoit Y, et al. Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia. J Allergy Clin Immunol. 2012;129(3):770\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2011.09.047 .","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"474_CR11","doi-asserted-by":"publisher","first-page":"e00079","DOI":"10.1128\/mBio.00079-12","volume":"3","author":"JD Langereis","year":"2012","unstructured":"Langereis JD, Stol K, Schweda EK, Twelkmeyer B, Bootsma HJ, de Vries SP, et al. Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media. MBio. 2012;3(4):e00079\u201312. https:\/\/doi.org\/10.1128\/mBio.00079-12 .","journal-title":"MBio"},{"issue":"4","key":"474_CR12","doi-asserted-by":"publisher","first-page":"e01478","DOI":"10.1128\/mBio.01478-14","volume":"5","author":"JD Langereis","year":"2014","unstructured":"Langereis JD, Weiser JN. Shielding of a lipooligosaccharide IgM epitope allows evasion of neutrophil-mediated killing of an invasive strain of nontypeable Haemophilus influenzae. MBio. 2014;5(4):e01478\u201314. https:\/\/doi.org\/10.1128\/mBio.01478-14 .","journal-title":"MBio"},{"issue":"8","key":"474_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1172\/JCI7696","volume":"104","author":"Y Minegishi","year":"1999","unstructured":"Minegishi Y, Coustan-Smith E, Rapalus L, Ersoy F, Campana D, Conley ME. Mutations in Igalpha (CD79a) result in a complete block in B-cell development. J Clin Invest. 1999;104(8):1115\u201321. https:\/\/doi.org\/10.1172\/JCI7696 .","journal-title":"J Clin Invest"},{"issue":"8497","key":"474_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0140-6736(86)92595-X","volume":"2","author":"MF Leahy","year":"1986","unstructured":"Leahy MF. Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia. Lancet. 1986;2(8497):48.","journal-title":"Lancet"},{"issue":"9","key":"474_CR15","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1172\/JCI76175","volume":"124","author":"B Bestas","year":"2014","unstructured":"Bestas B, Moreno PM, Blomberg KE, Mohammad DK, Saleh AF, Sutlu T, et al. Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model. J Clin Invest. 2014;124(9):4067\u201381. https:\/\/doi.org\/10.1172\/JCI76175 .","journal-title":"J Clin Invest"},{"issue":"11","key":"474_CR16","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1182\/blood-2009-09-241869","volume":"115","author":"HM Kerns","year":"2010","unstructured":"Kerns HM, Ryu BY, Stirling BV, Sather BD, Astrakhan A, Humblet-Baron S, et al. B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia. Blood. 2010;115(11):2146\u201355. https:\/\/doi.org\/10.1182\/blood-2009-09-241869 .","journal-title":"Blood"},{"issue":"3","key":"474_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1128\/CMR.00055-07","volume":"21","author":"R Janssen","year":"2008","unstructured":"Janssen R, Krogfelt KA, Cawthraw SA, van Pelt W, Wagenaar JA, Owen RJ. Host-pathogen interactions in campylobacter infections: the host perspective. Clin Microbiol Rev. 2008;21(3):505\u201318. https:\/\/doi.org\/10.1128\/CMR.00055-07 .","journal-title":"Clin Microbiol Rev"},{"issue":"2\u20133","key":"474_CR18","first-page":"171","volume":"24","author":"O Jirapongsananuruk","year":"2006","unstructured":"Jirapongsananuruk O, Wanotayan K, Phongsamart W, Chokephaibulkit K, Visitsunthorn N, Luangwedchakarn V, et al. Recurrent campylobacter lari bacteremia in X-linked agammaglobulinemia: a case report and review. Asian Pac J Allergy Immunol. 2006;24(2\u20133):171\u20134.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"9","key":"474_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/BF01960888","volume":"11","author":"PJ Kerstens","year":"1992","unstructured":"Kerstens PJ, Endtz HP, Meis JF, Oyen WJ, Koopman RJ, van den Broek PJ, et al. Erysipelas-like skin lesions associated with campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur J Clin Microbiol Infect Dis. 1992;11(9):842\u20137. https:\/\/doi.org\/10.1007\/BF01960888 .","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"474_CR20","doi-asserted-by":"publisher","first-page":"735108","DOI":"10.1155\/2013\/735108","volume":"2013","author":"P Ariganello","year":"2013","unstructured":"Ariganello P, Angelino G, Scarselli A, Salfa I, Della Corte M, De Matteis A, et al. Relapsing campylobacter jejuni systemic infections in a child with X-linked agammaglobulinemia. Case Rep Pediatr. 2013;2013(1):735108\u20133. https:\/\/doi.org\/10.1155\/2013\/735108 .","journal-title":"Case Rep Pediatr"},{"issue":"2","key":"474_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF02214947","volume":"14","author":"CH Simon","year":"1995","unstructured":"Simon CH, Markusse HM. Campylobacter jejuni arthritis in secondary amyloidosis. Clin Rheumatol. 1995;14(2):214\u20136. https:\/\/doi.org\/10.1007\/BF02214947 .","journal-title":"Clin Rheumatol"},{"issue":"4","key":"474_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S1081-1206(10)62036-4","volume":"89","author":"A Rafi","year":"2002","unstructured":"Rafi A, Matz J. An unusual case of campylobacter jejuni pericarditis in a patient with X-linked agammaglobulinemia. Ann Allergy Asthma Immunol. 2002;89(4):362\u20137. https:\/\/doi.org\/10.1016\/S1081-1206(10)62036-4 .","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"jan29 1","key":"474_CR23","doi-asserted-by":"publisher","first-page":"bcr0220102741","DOI":"10.1136\/bcr.02.2010.2741","volume":"2011","author":"S Hopkins","year":"2011","unstructured":"Hopkins S, Abuzakouk M, Brannigan E, Bergin C, Feighery C. Campylobacter jejuni cellulitis in a patient with pan-hypogammaglobulinaemia. BMJ Case Rep. 2011;2011(jan29 1):bcr0220102741. https:\/\/doi.org\/10.1136\/bcr.02.2010.2741.","journal-title":"BMJ Case Rep"},{"issue":"10","key":"474_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/BF02098467","volume":"12","author":"JC Borleffs","year":"1993","unstructured":"Borleffs JC, Schellekens JF, Brouwer E, Rozenberg-Arska M. Use of an immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with persistent campylobacter jejuni infection. Eur J Clin Microbiol Infect Dis. 1993;12(10):772\u20135. https:\/\/doi.org\/10.1007\/BF02098467 .","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"474_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/11024159950188493","volume":"584","author":"R Lissner","year":"1999","unstructured":"Lissner R, Struff WG, Autenrieth IB, Woodcock BG, Karch H. Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion. Eur J Surg Suppl. 1999;584:17\u201325.","journal-title":"Eur J Surg Suppl"},{"issue":"3","key":"474_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jcrc.2005.03.003","volume":"20","author":"AR Neilson","year":"2005","unstructured":"Neilson AR, Burchardi H, Schneider H. Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock. J Crit Care. 2005;20(3):239\u201349. https:\/\/doi.org\/10.1016\/j.jcrc.2005.03.003 .","journal-title":"J Crit Care"},{"issue":"2","key":"474_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jcrc.2011.05.012","volume":"27","author":"G Berlot","year":"2012","unstructured":"Berlot G, Vassallo MC, Busetto N, Bianchi M, Zornada F, Rosato I, et al. Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: a retrospective analysis. J Crit Care. 2012;27(2):167\u201371. https:\/\/doi.org\/10.1016\/j.jcrc.2011.05.012 .","journal-title":"J Crit Care"},{"issue":"4","key":"474_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/cc1523","volume":"6","author":"S Tugrul","year":"2002","unstructured":"Tugrul S, Ozcan PE, Akinci O, Seyhun Y, Cagatay A, Cakar N, et al. The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]. Crit Care. 2002;6(4):357\u201362. https:\/\/doi.org\/10.1186\/cc1523 .","journal-title":"Crit Care"},{"issue":"5","key":"474_CR29","doi-asserted-by":"publisher","first-page":"R213","DOI":"10.1186\/cc13028","volume":"17","author":"R Brunner","year":"2013","unstructured":"Brunner R, Rinner W, Haberler C, Kitzberger R, Sycha T, Herkner H, et al. Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and\/or myopathy in patients with multiple organ failure and SIRS\/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial. Crit Care. 2013;17(5):R213. https:\/\/doi.org\/10.1186\/cc13028 .","journal-title":"Crit Care"},{"issue":"6","key":"474_CR30","first-page":"451","volume":"9","author":"CH Poynton","year":"1992","unstructured":"Poynton CH, Jackson S, Fegan C, Barnes RA, Whittaker JA. Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation. Bone Marrow Transplant. 1992;9(6):451\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"474_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/petr.12636","volume":"20","author":"F Azik","year":"2016","unstructured":"Azik F, Bayram C, Erkocoglu M, Tezer H, Yazal Erdem A, Isik P, et al. Comparison of prophylactic use of intravenous immunoglobulin versus Pentaglobin(R) in pediatric patients after hematopoietic stem cell transplantation. Pediatr Transplant. 2016;20(2):276\u201383. https:\/\/doi.org\/10.1111\/petr.12636 .","journal-title":"Pediatr Transplant"},{"key":"474_CR32","doi-asserted-by":"publisher","unstructured":"Alejandria MM, Lansang MA, Dans LF, Mantaring JB 3rd. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev. 2013;9:CD001090. https:\/\/doi.org\/10.1002\/14651858.CD001090.pub2 .","DOI":"10.1002\/14651858.CD001090.pub2"},{"issue":"8","key":"474_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160907","volume":"11","author":"S Wand","year":"2016","unstructured":"Wand S, Klages M, Kirbach C, Warszawska J, Meybohm P, Zacharowski K, et al. IgM-enriched immunoglobulin attenuates systemic endotoxin activity in early severe sepsis: a before-after cohort study. PLoS One. 2016;11(8):e0160907. https:\/\/doi.org\/10.1371\/journal.pone.0160907 .","journal-title":"PLoS One"},{"issue":"10","key":"474_CR34","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1128\/AAC.36.10.2139","volume":"36","author":"G Behre","year":"1992","unstructured":"Behre G, Schedel I, Nentwig B, Wormann B, Essink M, Hiddemann W. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrob Agents Chemother. 1992;36(10):2139\u201346. https:\/\/doi.org\/10.1128\/AAC.36.10.2139 .","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"474_CR35","first-page":"8","volume":"76","author":"ND Garbett","year":"1989","unstructured":"Garbett ND, Munro CS, Cole PJ. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin. Clin Exp Immunol. 1989;76(1):8\u201312.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"474_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s15010-014-0706-1","volume":"43","author":"FS Rossmann","year":"2015","unstructured":"Rossmann FS, Kropec A, Laverde D, Saaverda FR, Wobser D, Huebner J. In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens. Infection. 2015;43(2):169\u201375. https:\/\/doi.org\/10.1007\/s15010-014-0706-1 .","journal-title":"Infection"},{"issue":"4","key":"474_CR37","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/aas.12652","volume":"60","author":"S Shmygalev","year":"2016","unstructured":"Shmygalev S, Damm M, Knels L, Strassburg A, Wunsche K, Dumke R, et al. IgM-enriched solution BT086 improves host defense capacity and energy store preservation in a rabbit model of endotoxemia. Acta Anaesthesiol Scand. 2016;60(4):502\u201312. https:\/\/doi.org\/10.1111\/aas.12652 .","journal-title":"Acta Anaesthesiol Scand"},{"issue":"12","key":"474_CR38","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.imbio.2017.09.002","volume":"222","author":"R Vaschetto","year":"2017","unstructured":"Vaschetto R, Clemente N, Pagni A, Esposito T, Longhini F, Mercalli F, et al. A double blind randomized experimental study on the use of IgM-enriched polyclonal immunoglobulins in an animal model of pneumonia developing shock. Immunobiology. 2017;222(12):1074\u201380. https:\/\/doi.org\/10.1016\/j.imbio.2017.09.002 .","journal-title":"Immunobiology"},{"issue":"6","key":"474_CR39","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.rmed.2015.03.008","volume":"109","author":"T Welte","year":"2015","unstructured":"Welte T, Dellinger RP, Ebelt H, Ferrer M, Opal SM, Schliephake DE, et al. Concept for a study design in patients with severe community-acquired pneumonia: a randomised controlled trial with a novel IGM-enriched immunoglobulin preparation - the CIGMA study. Respir Med. 2015;109(6):758\u201367. https:\/\/doi.org\/10.1016\/j.rmed.2015.03.008 .","journal-title":"Respir Med"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-017-0474-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0474-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0474-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T15:51:05Z","timestamp":1660319465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-017-0474-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1007\/s10875-017-0474-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]},"assertion":[{"value":"9 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}